InsidersTradesSigma
Track the Appili Therapeutics Inc. share price and the full management transaction log of the company, a listed equity based in Canada. Shares are quoted on CA CA, under the supervision of SEDI. The latest transaction was filed on 6 July 2026 (50 - Grant of options). Among the most active insiders: gowd, prakash. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
Appili Therapeutics Inc. is a biopharmaceutical company focused on developing treatments for infections and infectious diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.